New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For JBL;ARRS;GOOG;NYX;ICE;SD;ACN;BBBY;FOLD;GSK;MDRX From The Last 14 Days
Check below for free stories on JBL;ARRS;GOOG;NYX;ICE;SD;ACN;BBBY;FOLD;GSK;MDRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
April 22, 2014
08:51 EDTBBBYBed Bath & Beyond settles with NY AG over hiring practices
Subscribe for More Information
08:49 EDTGSKGSK, Theravance announce Phase III study of FF/VI in Japan
Subscribe for More Information
08:37 EDTGSKTheravance, GlaxoSmithKline receive Australian approval for Breo Ellipta
GlaxoSmithKline (GSK) and Theravance (THRX) announced that the Therapeutic Goods Administration has approved BREO ELLIPTA for the treatment of patients with asthma or chronic obstructive pulmonary disease, or COPD, in Australia. Two strengths of BREO ELLIPTA have been licensed for the treatment of asthma and one strength has been licensed for the treatment of COPD.
07:48 EDTGSKGlaxoSmithKline to host conference call
Subscribe for More Information
07:46 EDTGSKGlaxo thinks Novartis agreement could mean future disposals, Reuters says
Subscribe for More Information
06:37 EDTGOOGCompanies with cloud businesses worried about Aereo case, Re/code says
Subscribe for More Information
05:35 EDTGSKNovartis says transactions 'represent a transformation' for the company
The elements of the transaction with GSK (GSK) are inter-conditional and subject to approval by GSK shareholders. The Novartis (NVS) board unanimously believes that the transactions with GSK and the transaction with Lilly (LLY) are in the best interests of Novartis and the Novartis Shareholders as a whole. The transaction with Lilly is expected to close by the end of 1Q15 and the transaction with GSK is expected to close during the first half of 2015. The terms of the divestment of the Vaccines business would maximize the value of its pipeline, including Bexsero. The divestment of Animal Health would recognize the full value of the business. The transactions are expected to improve Novartis' sales and core operating income growth rates, while improving margins. Each of the transactions is projected to be value creating. The company commented, "These transactions represent a transformation for Novartis. We have leading positions in our core businesses in high-growth segments of healthcare. This will enable us to continue to build the world's most respected and successful healthcare company. Our strategic focus on science-based innovation and our global scale position the company well to meet the changes in the healthcare industry for the coming decade and beyond."
05:26 EDTGSKNovartis OTC, GSK Consumer Healthcare form joint venture
Subscribe for More Information
05:23 EDTGSKNovartis divests Vaccines business to GSK for $7.1B
Novartis (NVS) has agreed to divest its Vaccines business to GSK (GSK), currently excluding its flu business, for $7.1B plus royalties. The $7.1B consists of $5.25B upfront and up to $1.8B in milestones. As a part of a value-maximization strategy in the context of the portfolio review, Novartis has initiated a separate sales process for its flu business.
05:20 EDTGSKNovartis to acquire GSK oncology products for $14.5B
Subscribe for More Information
April 21, 2014
13:36 EDTGOOGGoogle wants to add encryption tools to Gmail, VentureBeat says
Subscribe for More Information
10:49 EDTGOOGOptions with decreasing implied volatility: SRPT NSR INFY CMG GOOG
Subscribe for More Information
10:01 EDTJBLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:32 EDTJBLJabil Circuit downgraded at RBC Capital
As noted earlier, RBC Capital downgraded Jabil Circuit (JBL) to Sector Perform from Outperform. As reasons for the downgrade, the firm cited concerns about Jabil circuit's largest customer, Apple (AAPL), as well as its belief that Jabil's FY15 guidance appears to reflect a best-case scenario. Target to $20 from $21.
06:51 EDTICENYSE, BofA among those sued regarding high-frequency trading, Bloomberg says
Subscribe for More Information
06:48 EDTGOOGMicrosoft faces internal & external conflicts in three segments, DigiTimes says
Subscribe for More Information
06:45 EDTGOOGApple and Google compete to offer exclusive game apps, WSJ reports
Subscribe for More Information
06:41 EDTGOOGGoogle to partner with HTC for 8-inch Nexus, DigiTimes reports
Subscribe for More Information
06:37 EDTGOOGSquare discusses possible sale as losses widen, WSJ reports
Mobile-payments startup Square discussed a possible sale to several rivals as its losses widen, reports the Wall Street Journal, citing people familiar with the matter. Google (GOOG) discussed a possible acquisition of the company earlier this year, but it was not clear if the talks were continuing. Square also had discussions about a deal with Apple (AAPL) and eBay's (EBAY) PayPal. Reference Link
06:26 EDTGOOGCourt documents say Silicon Valley giants discussed hiring, WSJ says
Google (GOOG), Apple (AAPL), Intel (INTC) and Adobe (ADBE had colluded with one another to supress wages between 2005 and 2009, reports the Wall Street Journal, citing documents from an antitrust case. The companies had agreed not to poach each other's employees among other things. The companies had also tried to bring Facebook (FB) on board, but Facebook rejected the offer. Reference Link
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use